Analyst Ratings for Immix Biopharma, Inc. (IMMX)
IMMX Rating Summary
IMMX Price Target Summary
- Highest: $27.00 (BofA Securities)
- Lowest: $15.00 (Mizuho)
- Average: $21.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.00 (+104.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$21.00 (+104.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/18/2026 | BofA Securities | Tazeen Ahmad | New Coverage | Buy (N/A) |
27.00 (N/A) |
9.13 (10.25) |
12.27% | Details |
| 3/25/2026 | Morgan Stanley | Judah Frommer | New Coverage | Overweight (N/A) |
20.00 (N/A) |
8.81 (10.25) |
16.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
